Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction?

doi:10.1016/j.jcin.2016.07.001

Editorial

. 2016 Aug 22;9(16):1649-51.

doi: 10.1016/j.jcin.2016.07.001.

Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction?

Anthony G Nappi¹, William E Boden²

Affiliations

¹ Albany Medical College, Albany, New York.
² Clinical Trials Network, VA New England Healthcare System, Boston, Massachusetts. Electronic address: william.boden@va.gov.

PMID: 27539684
DOI: 10.1016/j.jcin.2016.07.001

Free article

Editorial

Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction?

Anthony G Nappi et al. JACC Cardiovasc Interv. 2016.

Free article

. 2016 Aug 22;9(16):1649-51.

doi: 10.1016/j.jcin.2016.07.001.

Authors

Anthony G Nappi¹, William E Boden²

Affiliations

¹ Albany Medical College, Albany, New York.
² Clinical Trials Network, VA New England Healthcare System, Boston, Massachusetts. Electronic address: william.boden@va.gov.

PMID: 27539684
DOI: 10.1016/j.jcin.2016.07.001

No abstract available

Keywords: beta-blockers; coronary artery disease; percutaneous coronary intervention.

PubMed Disclaimer

Comment on

Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA, Parikh V, Roe M, Dai D, Abbott JD, Prasad A, Mukherjee D. Motivala AA, et al. JACC Cardiovasc Interv. 2016 Aug 22;9(16):1639-48. doi: 10.1016/j.jcin.2016.05.048. JACC Cardiovasc Interv. 2016. PMID: 27539683

Similar articles

Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Pérez de Prado A, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Ibanez B, et al. Circulation. 2013 Oct 1;128(14):1495-503. doi: 10.1161/CIRCULATIONAHA.113.003653. Epub 2013 Sep 3. Circulation. 2013. PMID: 24002794 Clinical Trial.
Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Li C, Sun Y, Shen X, Yu T, Li Q, Ruan G, Zhang L, Huang Q, Zhuang H, Huang J, Ni L, Wang L, Jiang J, Wang Y, Wang DW. Li C, et al. J Am Heart Assoc. 2016 Nov 16;5(11):e004190. doi: 10.1161/JAHA.116.004190. J Am Heart Assoc. 2016. PMID: 27852588 Free PMC article.
[The impact of pre-primary percutaneous coronary intervention β blocker use on the no-reflow phenomenon in patients with acute myocardial infarction].
Wang J, Chen Y, Wang C, Zhu X. Wang J, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Oct;42(10):822-6. Zhonghua Xin Xue Guan Bing Za Zhi. 2014. PMID: 25547444 Chinese.
Meta-Analysis of Relation Between Oral β-Blocker Therapy and Outcomes in Patients With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention.
Huang BT, Huang FY, Zuo ZL, Liao YB, Heng Y, Wang PJ, Gui YY, Xia TL, Xin ZM, Liu W, Zhang C, Chen SJ, Pu XB, Chen M, Huang DJ. Huang BT, et al. Am J Cardiol. 2015 Jun 1;115(11):1529-38. doi: 10.1016/j.amjcard.2015.02.057. Epub 2015 Mar 16. Am J Cardiol. 2015. PMID: 25862157 Review.
Is long-term beta-blocker therapy for myocardial infarction survivors still relevant in the era of primary percutaneous coronary intervention?
Shacham Y, Leshem-Rubinow E, Roth A. Shacham Y, et al. Isr Med Assoc J. 2013 Dec;15(12):770-4. Isr Med Assoc J. 2013. PMID: 24449984 Review.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction?

Affiliations

Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction?

Authors

Affiliations

Comment on

Similar articles

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical